HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [Leuk Res. 2016 Jul;46:61-68.].

AuthorsJun Fang, Ran Zhang, Huafang Wang, Mei Hong, Qiuling Wu, Dimin Nie, Yong You, Zhaodong Zhong, Weiming Li, Yu Hu, Linghui Xia
JournalLeukemia research (Leuk Res) Vol. 81 Pg. 107 (Jun 2019) ISSN: 1873-5835 [Electronic] England
PMID31109445 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: